Picchio, Camila A.
Nomah, Daniel K.
Araujo, Silvia G.
Rando-Segura, Ariadna
Fernández, Emma
Buti, Maria
Rodríguez-Tajes, Sergio
Lens, Sabela
Rodríguez-Frías, Francisco
Lazarus, Jeffrey V.
Article History
Received: 13 May 2021
Accepted: 6 August 2021
First Online: 25 August 2021
Competing interests
: CAP, DKN, SGA, ARS, EF and FRF have nothing to declare. MB reports advisory fees from Janssen and Gilead Sciences and grants from Gilead Sciences, outside the submitted work. SR reports speaker fees from Gilead Sciences and Abbvie, outside the submitted work. SL reports speaker/advisory fees from Gilead Sciences and Abbvie and grants from Gilead Sciences, outside the submitted work. JVL reports grants, personal fees and other from AbbVie and Gilead Sciences, personal fees from CEPHEID, GSK, Intercept and Janssen, and grants and personal fees from MSD, outside the submitted work.